CATB insider filings
CATABASIS PHARMACEUTICALS INC — 18 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-06-10. Screen CATB transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CATB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CATABASIS PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-06-10 | 4 | Harshbarger Benjamin — Chief Legal Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Komjathy Andrew — Chief Commercial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Nichols Andrew John — Chief Scientific Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Callori Fred — Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Violin Jonathan — Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Clauser Noah — Chief Financial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Beck Joanne T. — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Milne Jill C. — CEO and President, Director | Grant/award (A): 1,400,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Cole Hugh M — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Harshbarger Benjamin — Senior VP, General Counsel | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | LAPOINTE ANTHONY GREGG — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | BATE KENNETH — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | KISHBAUCH MICHAEL D — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Callori Fred — Director | Grant/award (A): 1,617 (derivative) @ $3,009.53 | EDGAR |
| 2021-02-03 | 4 | PERCEPTIVE ADVISORS LLC — Director, 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner Xontogeny, LLC — Director, 10% owner Perceptive Xontogeny Venture Fund, LP — Director, 10% owner EDELMAN JOSEPH — Director, 10% owner | Grant/award (A): 4,851 (derivative) @ $3,009.53 · Grant/award (A): 1,617 (derivative) @ $3,009.53 | EDGAR |
| 2021-02-01 | 4 | Violin Jonathan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-02-01 | 4 | Callori Fred — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2020-09-21 | 4 | Clauser Noah — Chief Financial Officer | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CATABASIS PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-03-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CATB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs